BridgeMD
New treatment option for MCI
Official title FACE Phase II (a Stage II Trial)
ClinicalTrials.gov ID: NCT07130669
What this study is testing
- What it's testing
- How to ensure adherence to computerized cognitive training in unsupervised circumstances (e.g., at-home, self-administered) in older adults at risk for Alzheimer's disease (AD) or AD related dementia (AD/ADRD) is understudied. The objective of the R33 study is to test a novel facial expression-based personalization engine (FPE) for monitoring and modulating real-time effective engagement, with an ultimate goal of enhancing long-term adherence in unsupervised cognitive training in older adults at risk for AD/ADRD.
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 60 to 89. Healthy volunteers may be eligible.
You may be able to join if
- English speaking
- Aged 60-89
- Living in a home, or independent- or assisted-living facility
- Adequate visual and hearing acuity
- Anti-depressants, antipsychotics, and/or anxiolytics have been stable for at least 7 days
You likely can't join if
- be enrolled in another intervention study aimed at improving cognition
- live in nursing home
- diagnosed with Multiple Sclerosis, TBI, chronic heart failure, Parkinson's disease, dementia
See the full eligibility criteria
- English speaking
- Aged 60-89
- Living in a home, or independent- or assisted-living facility
- Adequate visual and hearing acuity
- Anti-depressants, antipsychotics, and/or anxiolytics have been stable for at least 7 days
- Memory medications have been stable for at least 3 months
- Absence of neurological/vascular disorder (For neurological disorders with minor symptoms check with PI on case-by-case basis)
- be enrolled in another intervention study aimed at improving cognition
- live in nursing home
- diagnosed with Multiple Sclerosis, TBI, chronic heart failure, Parkinson's disease, dementia
The study team makes the final eligibility decision.
Where it's taking place
- Palo Alto, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 60 years to 89 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Palo Alto, California, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.